Combination of antibodies or their Fab fragments for use as drug ior pharmaceutic device containing these antibodies or their Fab fragments
Abstract
This patent describes use of antibodies against IL-6, IL-8 and CXCL-1 as agent influencing the crosstalk between cancer and stromal elements for therapeutic purposes